Transcatheter tricuspid valve repair toward a surgical standard: first-in-man report of direct annuloplasty with a cardioband device to treat severe functional tricuspid regurgitation
CardioBand™ (ValtechCardio, OrYehuda, Israel) is a transcatheter annuloplasty system designed to implant a Dacron surgical-like adjustable band with a sutureless technique under echocardiographic and fluoroscopic guidance. We describe the first-in-human clinical experience of treatment severe tricuspid regurgitation (TR) with this device. The ‘first-in-human’ patient was a 74-year-old woman with severe functional TR associated with tricuspid annular dilation and pacemaker lead. She was admitted in New York Heart Association functional class II after episode of decompensated heart failure. The EuroSCORE II–estimated risk of operative mortality was 7.0%. After multidisciplinary heart team discussion, the patient was considered eligible for transcatheter tricuspid valve (TV) annuloplasty. The intervention was performed under general anaesthesia, fluoroscopy, as well as transoesophageal echocardiography (TEE) guidance (PanelA). The catheter was advanced from anterior-septal commissure, in a clockwise direction, along the septal-posterior commissure (